Associations of anthropometric factors with KRAS and BRAF mutation status of primary colorectal cancer in men and women: A cohort study

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Brändstedt, Jenny ^a,b   Wangefjord, Sakarias ^a,b   Nodin, Björn ^a   Eberhard, Jakob ^a   Sundström, Magnus ^c   Manjer, Jonas ^a,b   Jirström, Karin ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BODY FAT DISTRIBUTION; BODY HEIGHT; BODY MASS; BODY WEIGHT; BRAF GENE; CANCER RISK; COHORT ANALYSIS; COLORECTAL CANCER; DISEASE ASSOCIATION; FEMALE; GENE MUTATION; HIP CIRCUMFERENCE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; ONCOGENE; ONCOGENE K RAS; PATHOGENESIS; PRIMARY TUMOR; PROSPECTIVE STUDY; PYROSEQUENCING; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; WAIST CIRCUMFERENCE; WAIST HIP RATIO; COLON; COLORECTAL NEOPLASMS; COMPLICATION; GENETICS; METABOLISM; MIDDLE AGED; MUTATION; PATHOLOGY; PROPORTIONAL HAZARDS MODEL;

B RAF KINASE; BRAF PROTEIN, HUMAN; KRAS PROTEIN, HUMAN; ONCOPROTEIN; RAS PROTEIN;

ADULT; AGED; BODY MASS INDEX; COHORT STUDIES; COLON; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; MUTATION; OBESITY; PROPORTIONAL HAZARDS MODELS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS B-RAF; RAS PROTEINS; RISK FACTORS; SEX FACTORS; WAIST-HIP RATIO;

EID: 84903386124     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0098964     Document Type: Article

References (56)

1. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, et al. (1988) Genetic alterations during colorectal-tumor development. N Engl J Med 319: 525-532.
2. Russo A, Rizzo S, Bronte G, Silvestris N, Colucci G, et al. (2009) The long and winding road to useful predictive factors for anti-EGFR therapy in metastatic colorectal carcinoma: the KRAS/BRAF pathway. Oncology 77 Suppl 1: 57-68.
3. Armaghany T, Wilson JD, Chu Q, Mills G (2012) Genetic alterations in colorectal cancer. Gastrointest Cancer Res 5: 19-27.
4. Pancione M, Remo A, Colantuoni V (2012) Genetic and epigenetic events generate multiple pathways in colorectal cancer progression. Patholog Res Int 2012: 509348.
5. Rosenberg DW, Yang S, Pleau DC, Greenspan EJ, Stevens RG, et al. (2007) Mutations in BRAF and KRAS differentially distinguish serrated versus non-serrated hyperplastic aberrant crypt foci in humans. Cancer Res 67: 3551-3554. (Pubitemid 46762136)
6. O'Brien MJ, Yang S, Mack C, Xu H, Huang CS, et al. (2006) Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. Am J Surg Pathol 30: 1491-1501. (Pubitemid 44808785)
7. Nash GM, Gimbel M, Cohen AM, Zeng ZS, Ndubuisi MI, et al. (2010) KRAS mutation and microsatellite instability: two genetic markers of early tumor development that influence the prognosis of colorectal cancer. Ann Surg Oncol 17: 416-424.
8. Phipps AI, Buchanan DD, Makar KW, Win AK, Baron JA, et al. (2013) KRAS-mutation status in relation to colorectal cancer survival: the joint impact of correlated tumour markers. Br J Cancer 108: 1757-1764.
9. Ogino S, Nosho K, Kirkner GJ, Kawasaki T, Meyerhardt JA, et al. (2009) CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer. Gut 58: 90-96.
10. Benvenuti S, Sartore-Bianchi A, Di Nicolantonio F, Zanon C, Moroni M, et al. (2007) Oncogenic activation of the RAS/RAF signaling pathway impairs the response of metastatic colorectal cancers to anti-epidermal growth factor receptor antibody therapies. Cancer Res 67: 2643-2648. (Pubitemid 46548951)
11. Kim IJ, Kang HC, Jang SG, Kim K, Ahn SA, et al. (2006) Oligonucleotide microarray analysis of distinct gene expression patterns in colorectal cancer tissues harboring BRAF and K-ras mutations. Carcinogenesis 27: 392-404. (Pubitemid 43372868)
12. Deng G, Kakar S, Tanaka H, Matsuzaki K, Miura S, et al. (2008) Proximal and distal colorectal cancers show distinct gene-specific methylation profiles and clinical and molecular characteristics. Eur J Cancer 44: 1290-1301.
13. Yokota T, Ura T, Shibata N, Takahari D, Shitara K, et al. (2011) BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancer. Br J Cancer 104: 856-862.
14. Samowitz WS, Sweeney C, Herrick J, Albertsen H, Levin TR, et al. (2005) Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers. Cancer Res 65: 6063-6069.
15. Farina-Sarasqueta A, van Lijnschoten G, Moerland E, Creemers GJ, Lemmens VE, et al. (2010) The BRAF V600E mutation is an independent prognostic factor for survival in stage II and stage III colon cancer patients. Ann Oncol 21: 2396-2402.
16. Wangefjord S, Sundstrom M, Zendehrokh N, Lindquist KE, Nodin B, et al. (2013) Sex differences in the prognostic significance of KRAS codons 12 and 13, and BRAF mutations in colorectal cancer: a cohort study. Biol Sex Differ 4: 17.
17. Larsson SC, Wolk A (2007) Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies. Am J Clin Nutr 86: 556-565. (Pubitemid 47435820)
18. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371: 569-578. (Pubitemid 351232031)
19. Slattery ML, Curtin K, Wolff RK, Herrick JS, Caan BJ, et al. (2010) Diet, physical activity, and body size associations with rectal tumor mutations and epigenetic changes. Cancer Causes Control 21: 1237-1245.
20. Hughes LA, Williamson EJ, van Engeland M, Jenkins MA, Giles GG, et al. (2012) Body size and risk for colorectal cancers showing BRAF mutations or microsatellite instability: a pooled analysis. Int J Epidemiol 41: 1060-1072.
21. Berglund G, Elmstahl S, Janzon L, Larsson SA (1993) The Malmo Diet and Cancer Study. Design and feasibility. J Intern Med 233: 45-51.
22. Wangefjord S, Manjer J, Gaber A, Nodin B, Eberhard J, et al. (2011) Cyclin D1 expression in colorectal cancer is a favorable prognostic factor in men but not in women in a prospective, population-based cohort study. Biol Sex Differ 2: 10.
23. Larsson A, Johansson ME, Wangefjord S, Gaber A, Nodin B, et al. (2011) Overexpression of podocalyxin-like protein is an independent factor of poor prognosis in colorectal cancer. Br J Cancer 105: 666-672.
24. Wangefjord S, Brandstedt J, Lindquist KE, Nodin B, Jirstrom K, et al. (2013) Associations of beta-catenin alterations and MSI screening status with expression of key cell cycle regulating proteins and survival from colorectal cancer. Diagn Pathol 8: 10.
25. Steen B, Bosaeus I, Elmstahl S, Galvard H, Isaksson B, et al. (1987) Body composition in the elderly estimated with an electrical impedance method. Compr Gerontol A 1: 102-105.
26. Katz MH, Hauck WW (1993) Proportional hazards (Cox) regression. J Gen Intern Med 8: 702-711. (Pubitemid 23358541)
27. Giovannucci E, Colditz GA, Stampfer MJ, Hunter D, Rosner BA, et al. (1994) A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in U.S. women. J Natl Cancer Inst 86: 192-199. (Pubitemid 24042260)
28. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A, et al. (1994) Intake of fat, meat, and fiber in relation to risk of colon cancer in men. Cancer Res 54: 2390-2397. (Pubitemid 24138730)
29. Cho E, Smith-Warner SA, Ritz J, van den Brandt PA, Colditz GA, et al. (2004) Alcohol intake and colorectal cancer: a pooled analysis of 8 cohort studies. Ann Intern Med 140: 603-613.
30. Chen K, Jiang Q, Ma X, Li Q, Yao K, et al. (2005) Alcohol drinking and colorectal cancer: a population-based prospective cohort study in China. Eur J Epidemiol 20: 149-154. (Pubitemid 40568420)
31. Palmer RC, Schneider EC (2005) Social disparities across the continuum of colorectal cancer: a systematic review. Cancer Causes Control 16: 55-61. (Pubitemid 40568851)
32. Pritchard CC, Grady WM (2011) Colorectal cancer molecular biology moves into clinical practice. Gut 60: 116-129.
33. Slattery ML, Curtin K, Anderson K, Ma KN, Ballard L, et al. (2000) Associations between cigarette smoking, lifestyle factors, and microsatellite instability in colon tumors. J Natl Cancer Inst 92: 1831-1836.
34. Morikawa T, Kuchiba A, Yamauchi M, Meyerhardt JA, Shima K, et al. (2011) Association of CTNNB1 (beta-catenin) alterations, body mass index, and physical activity with survival in patients with colorectal cancer. JAMA 305: 1685-1694.
35. Hughes LA, Simons CC, van den Brandt PA, Goldbohm RA, de Goeij AF, et al. (2011) Body size, physical activity and risk of colorectal cancer with or without the CpG island methylator phenotype (CIMP). PLoS One 6: e18571.
36. Slattery ML, Anderson K, Curtin K, Ma K, Schaffer D, et al. (2001) Lifestyle factors and Ki-ras mutations in colon cancer tumors. Mutat Res 483: 73-81. (Pubitemid 33000068)
37. Hutchins G, Southward K, Handley K, Magill L, Beaumont C, et al. (2011) Value of mismatch repair, KRAS, and BRAF mutations in predicting recurrence and benefits from chemotherapy in colorectal cancer. J Clin Oncol 29: 1261-1270.
38. Samowitz WS, Curtin K, Schaffer D, Robertson M, Leppert M, et al. (2000) Relationship of Ki-ras mutations in colon cancers to tumor location, stage, and survival: a population-based study. Cancer Epidemiol Biomarkers Prev 9: 1193-1197.
39. Bazan V, Migliavacca M, Zanna I, Tubiolo C, Grassi N, et al. (2002) Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype. Ann Oncol 13: 1438-1446.
40. Zlobec I, Kovac M, Erzberger P, Molinari F, Bihl MP, et al. (2010) Combined analysis of specific KRAS mutation, BRAF and microsatellite instability identifies prognostic subgroups of sporadic and hereditary colorectal cancer. Int J Cancer 127: 2569-2575.
41. Roth AD, Tejpar S, Delorenzi M, Yan P, Fiocca R, et al. (2010) Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial. J Clin Oncol 28: 466-474.
42. Kalady MF, Dejulius KL, Sanchez JA, Jarrar A, Liu X, et al. (2012) BRAF mutations in colorectal cancer are associated with distinct clinical characteristics and worse prognosis. Dis Colon Rectum 55: 128-133.
43. Popat S, Hubner R, Houlston RS (2005) Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol 23: 609-618. (Pubitemid 46224239)
44. Kim GP, Colangelo LH, Wieand HS, Paik S, Kirsch IR, et al. (2007) Prognostic and predictive roles of high-degree microsatellite instability in colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project Collaborative Study. J Clin Oncol 25: 767-772. (Pubitemid 350002875)
45. Bond CE, Umapathy A, Buttenshaw RL, Wockner L, Leggett BA, et al. (2012) Chromosomal instability in BRAF mutant, microsatellite stable colorectal cancers. PLoS One 7: e47483.
46. Brandstedt J, Wangefjord S, Borgquist S, Nodin B, Eberhard J, et al. (2013) Influence of anthropometric factors on tumour biological characteristics of colorectal cancer in men and women: a cohort study. J Transl Med 11: 293.
47. Slattery ML, Curtin K, Sweeney C, Levin TR, Potter J, et al. (2007) Diet and lifestyle factor associations with CpG island methylator phenotype and BRAF mutations in colon cancer. Int J Cancer 120: 656-663. (Pubitemid 44969038)
48. Brandstedt J, Wangefjord S, Nodin B, Gaber A, Manjer J, et al. (2012) Gender, anthropometric factors and risk of colorectal cancer with particular reference to tumour location and TNM stage: a cohort study. Biol Sex Differ 3: 23.
49. Slattery ML, Ballard-Barbash R, Edwards S, Caan BJ, Potter JD (2003) Body mass index and colon cancer: an evaluation of the modifying effects of estrogen (United States). Cancer Causes Control 14: 75-84. (Pubitemid 36403272)
50. Reeves GK, Pirie K, Beral V, Green J, Spencer E, et al. (2007) Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ 335: 1134.
51. Giovannucci E, Ascherio A, Rimm EB, Colditz GA, Stampfer MJ, et al. (1995) Physical activity, obesity, and risk for colon cancer and adenoma in men. Ann Intern Med 122: 327-334.
52. MacInnis RJ, English DR, Hopper JL, Haydon AM, Gertig DM, et al. (2004) Body size and composition and colon cancer risk in men. Cancer Epidemiol Biomarkers Prev 13: 553-559. (Pubitemid 38737890)
53. MacInnis RJ, English DR, Hopper JL, Gertig DM, Haydon AM, et al. (2006) Body size and composition and colon cancer risk in women. Int J Cancer 118: 1496-1500.
54. Pischon T, Lahmann PH, Boeing H, Friedenreich C, Norat T, et al. (2006) Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst 98: 920-931. (Pubitemid 44018922)
55. Krotkiewski M, Bjorntorp P, Sjostrom L, Smith U (1983) Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution. J Clin Invest 72: 1150-1162. (Pubitemid 14212633)
56. Manjer J, Carlsson S, Elmstahl S, Gullberg B, Janzon L, et al. (2001) The Malmo Diet and Cancer Study: representativity, cancer incidence and mortality in participants and non-participants. Eur J Cancer Prev 10: 489-499. (Pubitemid 34048904)